SEC Form 4 · accession 0001209191-17-023161
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S Weishar
Officer — Chief Executive Officer · Director
Period of report
Mar 24, 2017
Accepted (ET)
Mar 28, 2017 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value | Mar 24, 2017 | A | 24,109 | $0.00 | A | 972,846 | D | |
| Common Stock, $0.01 par value | Mar 24, 2017 | F | 12,054 | $23.60 | D | 960,792 | D | |
| Common Stock, $0.01 par value | holding | — | — | — | 1,500 | I | By Son |
Table II — derivative securities
No Table II lines on this filing.